Search results for

Masanori Tosu On November 25 2014, an amendment to the Pharmaceuticals and Medical Devices Law (the Law) came into effect and introduced important changes to Japan's medical products regulatory regime, including the establishment of regulations for regenerative medical products (for example, regenerative medicines using iPS cells). Indeed, since the Minister of Health, Labour and Welfare issued the first marketing authorisations for two regenerative medical products on September 18 2015, the medical products business in Japan and its regulation have received a good deal of attention.

When entering in to swaps with an international organisation, what do you need to think about to sleep easy? Hogan Lovells’ James Doyle and Oliver West have the answers

Stikeman Elliott’s Jeffrey Singer explains why, until recent reforms are approved, M&A parties must play according to the existing and proposed rules

Cleary Gottlieb’s Gabriele Apfelbacher, Michael Kern and Valentin Pfisterer explain the new waterfall for bank bonds

Paul Volcker, former Federal Reserve chairman, spoke exclusively to IFLR about his eponymous rule last month. He said the Volcker Rule, a part of the 2010 Dodd-Frank Act, has carried out his basic intent: banning federally-backed banks from speculative activity. But Volcker believes that more clarity is needed over the regulation.

Something for boards to aspire to European boards are finally prioritising the implementation of defence plans against activist investors as volumes look set to break records.

Shearman & Sterling’s Barney Reynolds, Danforth Newcomb and James Campbell discuss aspects of the nuclear deal that create real risks for foreign investors

Rulemakers in the region want a common regulatory infrastructure rather than simply importing Western regimes

France’s securities regulator has slapped a €5 million fine on the national stock exchange and a high frequency trading firm in relation to market manipulation

The country's regulators say they drew from others’ lessons when drafting the new law. So far it’s produced more questions than answers